Ionis Pharmaceuticals (IONS) Finished Goods (2018 - 2025)

Ionis Pharmaceuticals' Finished Goods history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2025.

• In Q1 2025, Finished Goods rose 959.0% year-over-year to $2.1 million; the TTM figure through Mar 2025 stood at $2.1 million (up 959.0% YoY), while the FY2024 annual figure was $276000.0, up 79.22% from the prior year.
• Finished Goods was $2.1 million for Q1 2025 at Ionis Pharmaceuticals, up from $276000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $2.1 million in Q1 2025 to a low of $63000.0 in Q3 2024.
• Historically, Finished Goods has averaged $563294.1 across 5 years, with a median of $288000.0 in 2022.
• The sharpest annual moves came in 2021 and 2025: Finished Goods sank 87.02% in 2021, then jumped 959.0% in 2025.
• A 5-year view of Finished Goods shows it stood at $390000.0 in 2021, then plunged by 57.95% to $164000.0 in 2022, then decreased by 6.1% to $154000.0 in 2023, then surged by 79.22% to $276000.0 in 2024, then surged by 667.39% to $2.1 million in 2025.
• The last three Finished Goods figures came in at $2.1 million (Q1 2025), $276000.0 (Q4 2024), and $63000.0 (Q3 2024), per Business Quant data.